New strategies for the treatment of immune thrombocytopenia. | Clin Adv Hematol Oncol;20(3): 151-153, 2022 03. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

New strategies for the treatment of immune thrombocytopenia.

Kessler, Craig M.

Affiliation

Kessler CM; Department of Medicine and Pathology, Division of Hematology/Oncology, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC.

Clin Adv Hematol Oncol ; 20(3): 151-153, 2022 03.

Article in En | MEDLINE | ID: mdl-36607344

Subject(s)

Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia; Humans; Purpura, Thrombocytopenic, Idiopathic/diagnosis; Purpura, Thrombocytopenic, Idiopathic/drug therapy

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Thrombocytopenia / Purpura, Thrombocytopenic, Idiopathic Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Clin Adv Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Document type: Article

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Thrombocytopenia / Purpura, Thrombocytopenic, Idiopathic Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Clin Adv Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2022 Document type: Article